Novartis Division Alcon Receives FDA Approval for AcrySof®IQ Aspheric IOL with UltraSert Pre-loaded Delivery System
October 05, 2015 at 04:14 AM EDT
Alcon, the global leader in eye care and a division of Novartis (NYSE: NVS), has received US Food and Drug Administration (FDA) approval ...
